Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- SciLifeLab
- ETH Zürich
- Agencia Estatal Consejo Superior de Investigaciones Científicas
- CNRS
- Georgia Southern University
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Leiden University
- Ludwig-Maximilians-Universität München •
- Medical University of Graz
- NTNU Norwegian University of Science and Technology
- National Institute of Research and Innovation
- Purdue University
- REQUIMTE - Rede de Quimica e Tecnologia
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- The Ohio State University
- The University of Arizona
- UNIVERSITY OF HELSINKI
- University of Arkansas
- University of Bonn •
- University of Cologne •
- University of Copenhagen
- University of Oslo
- University of Salerno
- University of Twente (UT)
- VIB
- Łukasiewicz Research Network - Krakow Institute of Technology
- 16 more »
- « less
-
Field
-
international and interdisciplinary research environment. The successful candidate will work at the forefront of structural biology and drug discovery, addressing fundamental questions with direct relevance
-
. The PhD will contribute directly to the development of technologies that may accelerate drug discovery, personalized medicine, and the transition toward advanced animal-free testing methods. Your immediate
-
The PhD in Drug Discovery and Development is an advanced training program designed to prepare highly qualified researchers in the field of pharmaceutical sciences. The program adopts a multidisciplinary
-
students to join a newly funded LOOP Zurich Flagship Project focused on advancing a breakthrough technology to clinic for non-invasive targeted drug delivery to the brain. Our laboratory recently developed a
-
, integrate genomics, epitranscriptomics and transcriptomics data, and contribute to the development of novel systems biology and bioinformatics methods for RNA therapeutic target discovery. The project is led
-
a dynamic environment that encourages learning, discovery and personal growth. The University is accredited by the Southern Association of Colleges and Schools and has earned specialized accreditation
-
institute specializing in organic chemistry, pharmaceutical research, molecular biology and bioorganic chemistry and is leading drug discovery center in the Baltic countries. Within the BBCE project
-
and Drug Safety is looking for a: PhD candidateGenetic Susceptibility in Stem Cell-Derived Organoid Safety Testing Why do people respond differently to harmful substances, and why are some individuals
-
find more details on this website . Combined Master's degree / PhD programme No Joint degree / double degree programme No Description/content Bonn International Graduate School of Drug Sciences (BIGS
-
) at The Ohio State University and become a part of a dynamic, forward-thinking team dedicated to pushing the boundaries of discovery and innovation. ERIK positions Ohio State to expand curiosity-driven research